CD25-SPECIFIC ANTIBODIES AND USES THEREOF
European Patent
23745029.1
Filed on 2025-01-14
23745029.1
Filed on 2025-01-14
CD25-SPECIFIC ANTIBODIES AND USES THEREOF
US Application 18/878,317
Filed on 2024-12-23
Filed on 2024-12-23
CD25-SPECIFIC ANTIBODIES AND USES THEREOF
China
202380063234.8
Filed on 2025-02-28
202380063234.8
Filed on 2025-02-28
CD25-SPECIFIC ANTIBODIES AND USES THEREOF
Australia
2023299296
Filed on 2024-12-20
2023299296
Filed on 2024-12-20
CD25-SPECIFIC ANTIBODIES AND USES THEREOF
Canada
3260932
Filed on 2024-12-30
3260932
Filed on 2024-12-30
CD25-SPECIFIC ANTIBODIES AND USES THEREOF
India
202517002483
Filed on 2025-01-10
202517002483
Filed on 2025-01-10
CD25-SPECIFIC ANTIBODIES AND USES THEREOF
Japan
2024-577174
Filed on 2024-12-27
2024-577174
Filed on 2024-12-27
A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER
United Kingdom
19707221.8
Filed on 2019-02-08
19707221.8
Filed on 2019-02-08
A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER
Germany
19707221.8
Filed on 2019-02-08
19707221.8
Filed on 2019-02-08
A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER
France
19707221.8
Filed on 2019-02-08
19707221.8
Filed on 2019-02-08